相关实验视频
Updated: Jul 2, 2025

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.4K
美国关于皮肤状细胞和基底细胞癌的管理指南的比较分析
Amit Mittal1, Bharat B Mittal2
1Department of Dermatology, Mayo Clinic College of Medicine & Science, 200 First St SW, Rochester, MN 55905, USA.
Journal of skin cancer
|February 19, 2024
概括
美国关于皮肤癌管理的指导方针,包括皮肤状细胞癌 (cSCC) 和皮肤基础细胞癌 (cBCC),在手术方面达成共识,但在辅助治疗建议方面存在差异. 为了获得最佳的患者护理,需要进一步的研究.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 基于证据的医学基于证据的医学.
背景情况:
- 对最近美国指南管理皮肤状细胞癌 (cSCC) 和皮肤基础细胞癌 (cBCC) 的比较分析.
- 专注于2016年6月1日至2022年12月1日期间发布的指南.
- 管理策略的分析,包括分期,原发性瘤治疗,区域节点管理和息治疗.
研究的目的:
- 为了比较和分析最近发表的美国关于cSCC和cBCC管理的指南.
- 在主要的皮肤学和瘤学组织中确定共识和分歧的领域.
- 突出未来研究皮肤癌治疗方案的机会.
主要方法:
- 在PubMed数据库中搜索2016年6月至2022年12月的指导方针.
- 美国皮肤病学会 (AAD),国家综合癌症网络 (NCCN) 和美国放射瘤学会 (ASTRO) 的指导方针的比较分析.
- 跨临床领域的评估:分期,风险分层,治疗意图管理和息治疗.
主要成果:
- 手术是cBCC和cSCC的首选治疗方法.
- 对于手术不合格的患者,建议进行终极辐射.
- 在证据分级,局部模式建议和术后放射治疗 (PORT) 标准方面存在差异.
- 神经侵袭的定义和PORT的指示显示了变化.
- 关于淋巴结转移的手术的共识,对PORT和全身治疗的考虑有不同的标准.
结论:
- 美国指南为cBCC和cSCC管理提供了当前和补充信息.
- 进一步研究的领域包括分期,辅助治疗指示,神经侵袭预后和全身治疗作用.
- 标准化证据分类和处理标准可以提高指南的一致性.
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186

